Steven Davidoff Solomon

Theranos under pressure as inquiries mount

Steven Davidoff Solomon and Peter J. Henning write for The New York Times, April 20, 2016

Like most private companies, Theranos shares have not been made available to the general investing public. But that does not exempt the company from the anti-fraud provisions of the federal securities laws.

Professors sue American Studies Association for boycott of Israel

Steven Davidoff Solomon quoted in The Algemeiner, April 20, 2016

“This appears to be a clear example of a small group misappropriating assets raised for an agreed-upon purpose and illegally using the organization to advance a completely separate and personal agenda,” said University of California, Berkeley Law School Professor Steven Davidoff Solomon, a corporate law expert who advised the litigation group representing the plaintiffs.

S.E.C. in stasis as democrats hold up Obama nominees

Steven Davidoff Solomon writes for The New York Times, April 19, 2016

That senators would hold up a nomination is no surprise, but this time it is an act rich with irony. The two nominees, Hester Peirce and Lisa M. Fairfax, were cleared by these same Democratic senators after a revolt over the White House’s first proposed nominee, Keir D. Gumbs, a partner at the law firm Covington & Burling.

An activism-shy BlackRock throws a surprise punch

Steven Davidoff Solomon writes for The New York Times, April 5, 2016

BlackRock has run its first significant activist campaign, and that means something. Activists, however short- or long-termist, have beaten an extremely well-worn path for how to influence companies. That BlackRock is using that path shows how worn it is; BlackRock is now willing to challenge management openly when the line is crossed.

Explaining Valeant: The main theories

Steven Davidoff Solomon writes for The New York Times, March 29, 2016

There is no doubt that Valeant has taken a major hit. The crisis has crushed its previous business model of raising prices and making acquisitions. This has left it a company in transition. … but wherever it goes from here, one can’t ignore the business it already has—with billions of dollars in earnings.